Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Stock data | 2024 | Change |
---|---|---|
Price | $7.33 | N/A |
Market Cap | $374.13M | N/A |
Shares Outstanding | 51.06M | N/A |
Employees | 523.00 | N/A |